SCHEMBL4552219

SCHEMBL4552219

C=CCNCC[O]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1083159 0.83
SCHEMBL368094 0.81 ADRB2 (0.35)
SCHEMBL6425687 0.79 PAOX (0.39)
SCHEMBL5611699 0.78 ADRB2 (0.34)
SCHEMBL5611639 0.78 ADRB2 (0.34)
SCHEMBL20143510 0.77
SCHEMBL3023756 0.75 PAOX (0.50)
SCHEMBL1948513 0.75 KDM1A (0.43)
SCHEMBL2478334 0.74
Formaldehyde SCHEMBL11566715 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0121171-B1 FUNGICIDES, PROCESS FOR THEIR PREPARATION AND THEIR USE BAYER AG (DE) 1989-05-10 EP claimed
EP-0121171-A2 Fungicides, process for their preparation and their use BAYER AG (DE) 1984-10-10 EP claimed
EP-0105166-A1 Substituted tert. butanol derivatives, method for their preparation and antimycotic agents containing them BAYER AG (DE) 1984-04-11 EP claimed
JP-57024355-A None JP disclosed
CN-107406539-B Continuous gas phase polymerization process 巴塞尔聚烯烃股份有限公司 2020-04-07 CN disclosed
CN-101528231-A Use of PI3K and MEK modulators in the treatment of cancer EXELIXIS INC (US) 2009-09-09 CN disclosed
EP-1487436-A4 COMBINATION THERAPY FOR TREATING, PREVENTING OR MANAGING PROLIFERATIVE DISORDERS AND CANCERS SIGNAL PHARM INC (US) 2009-06-03 EP disclosed
US-7501516-B2 Quinoline derivatives and their use as tyrosine kinase inhibitors ASTRAZENECA AB (SE) 2009-03-10 US disclosed
US-7351729-B2 JNK inhibitors for use in combination therapy for treating or managing proliferative disorders and cancers SIGNAL PHARMACEUTICALS, LLC (US) 2008-04-01 US disclosed
US-20070225209-A1 COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS AND DISEASES MYRIAD GENETICS, INCORPORATED (US) 2007-09-27 US disclosed
US-20070149571-A1 Combination therapy for treating or managing acute myelocytic leukemia SIGNAL PHARMACEUTICALS, LLC 2007-06-28 US disclosed
US-4621095-A BIS-AZOLYL-SUBSTITUTED TERT-BUTANOL DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 1986-11-04 US disclosed
US-4618619-A Substituted t-butanol fungicidal agents BAYER AKTIENGESELLSCHAFT (DE) 1986-10-21 US disclosed
US-4618619-A Substituted t-butanol fungicidal agents BAYER AKTIENGESELLSCHAFT (DE) 1986-10-21 US disclosed
US-4565569-A HERBICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1986-01-21 US disclosed
EP-0153160-A1 Novel cytotoxic aminoalkyl phenol ethers The University of Manitoba (CA) 1985-08-28 EP disclosed
EP-0121171-A2 Fungicides, process for their preparation and their use BAYER AG (DE) 1984-10-10 EP disclosed
EP-0105166-A1 Substituted tert. butanol derivatives, method for their preparation and antimycotic agents containing them BAYER AG (DE) 1984-04-11 EP disclosed
EP-0105166-A1 Substituted tert. butanol derivatives, method for their preparation and antimycotic agents containing them BAYER AG (DE) 1984-04-11 EP disclosed
JP-S5724355-A NOVEL DIPHENYL ETHER TYPE COMPOUND MITSUI TOATSU CHEM INC 1982-02-08 JP disclosed